Cargando…
Comprehensive Analysis of N(6)-Methyladenosine (m(6)A) Methylation in Neuromyelitis Optica Spectrum Disorders
Background: N(6)-Methyladenosine (m(6)A) methylation is the most prevalent internal posttranscriptional modification on mammalian mRNA. But its role in neuromyelitis optica spectrum disorders (NMOSD) is not known. Aims: To explore the mechanism of m(6)A in NMOSD patients. Methods: This study assesse...
Autores principales: | Yang, Hong, Wu, Yi-Fan, Ding, Jie, Liu, Wei, Zhu, De-Sheng, Shen, Xia-Feng, Guan, Yang-Tai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8660110/ https://www.ncbi.nlm.nih.gov/pubmed/34899833 http://dx.doi.org/10.3389/fgene.2021.735454 |
Ejemplares similares
-
Comprehensive analysis of the expression of N6-methyladenosine RNA methylation regulators in pulmonary artery hypertension
por: Zheng, Hao, et al.
Publicado: (2022) -
Interleukin-6 in neuromyelitis optica spectrum disorder pathophysiology
por: Fujihara, Kazuo, et al.
Publicado: (2020) -
Treatment of neuromyelitis optica/neuromyelitis optica spectrum disorders with methotrexate
por: Ramanathan, Ramnath Santosh, et al.
Publicado: (2014) -
Multi-Level Analyses of Genome-Wide Association Study to Reveal Significant Risk Genes and Pathways in Neuromyelitis Optica Spectrum Disorder
por: Li, Ting, et al.
Publicado: (2021) -
Current Advances in N6-Methyladenosine Methylation Modification During Bladder Cancer
por: Liu, Qiang
Publicado: (2022)